Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1968032

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1968032

Global HLA Typing Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 162 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The HLA Typing Market size is expected to reach USD 2.57 Billion in 2034 from USD 1.39 Billion (2025) growing at a CAGR of 7.04% during 2026-2034.

The Global HLA Typing Market is witnessing strong growth due to increasing organ transplantation procedures and rising awareness about tissue compatibility testing. Human Leukocyte Antigen (HLA) typing plays a critical role in bone marrow and solid organ transplants. Growing cases of chronic diseases leading to organ failure are boosting demand for accurate and advanced HLA testing solutions worldwide.

Key growth drivers include advancements in molecular diagnostic technologies such as next-generation sequencing (NGS) and PCR-based assays. Expanding donor registries and government support for transplant programs are also contributing to market growth. Research in immunology and personalized medicine further strengthens the demand for precise HLA typing in clinical and research settings.

Future growth is expected to be driven by technological innovations, automation in laboratories, and increasing global transplant volumes. Emerging markets are investing in healthcare infrastructure, which will create new opportunities. Additionally, the integration of bioinformatics tools for improved data analysis will enhance testing accuracy and efficiency, supporting sustained market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Instruments
  • Reagents & Consumables
  • Software & Services

By Application

  • Diagnosis
  • Research

By Technique

  • Molecular Assay
  • Sequenced-based Molecular Assay
  • Non-Molecular Assay

By End User

  • Commercial Service Providers
  • Hospitals and Transplant Centers
  • Research Labs & Academic Institutes

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, BioRad Laboratories Inc, Qiagen NV, Omixon Inc, GenDx, Illumina Inc, TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc, F HoffmanLa Roche Limited, Pacific Biosciences
  • We can customise the report as per your requirements.
Product Code: VMR112110056

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HLA TYPING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HLA TYPING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HLA TYPING MARKET: BY TECHNIQUE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Technique
  • 6.2. Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Sequenced-based Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Non-Molecular Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HLA TYPING MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Commercial Service Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Hospitals and Transplant Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Research Labs & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HLA TYPING MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Application
    • 8.2.3 By Technique
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Application
    • 8.3.3 By Technique
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Application
    • 8.4.3 By Technique
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Application
    • 8.5.3 By Technique
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Application
    • 8.6.3 By Technique
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HLA TYPING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher Scientific Inc
    • 10.2.2 Bio-Rad Laboratories Inc
    • 10.2.3 Qiagen N.V
    • 10.2.4 Omixon Inc
    • 10.2.5 GenDx
    • 10.2.6 Illumina Inc
    • 10.2.7 TBG Diagnostics Limited
    • 10.2.8 Dickinson And Company
    • 10.2.9 Takara Bio Inc
    • 10.2.10 F. Hoffman-La Roche Limited
    • 10.2.11 Pacific Biosciences
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!